Literature DB >> 17009161

Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor.

Min-Cheng Su1, Chia-Chi Wang, Chun-Chin Chen, Rey-Heng Hu, Ting-Huang Wang, Hsin-Lien Kao, Yung-Ming Jeng, Ray-Hwang Yuan.   

Abstract

BACKGROUND: Carcinoid tumors are a group of heterogeneous tumors with neuroendocrine differentiation and are mainly located in the gastrointestinal tract. A high frequency of cytoplasmic accumulation and/or nuclear translocation of beta-catenin with frequent mutations of exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor has been previously described, but the role of Wnt/beta-catenin/APC pathway in the genesis of carcinoid tumor remains largely unknown.
METHODS: To further characterize the role of Wnt/beta-catenin/APC pathway, we investigated 91 gastrointestinal carcinoid tumors and, for comparison, 26 extragastrointestinal carcinoid tumors by immunohistochemical detection of beta-catenin protein and direct sequencing of exon 3 of the beta-catenin gene and exon 15 of the APC gene.
RESULTS: Cytoplasmic accumulation and/or nuclear translocation of beta-catenin were found in 27 gastrointestinal carcinoid tumors (29.7%) but not in any extragastrointestinal carcinoid tumors. Interestingly, neither beta-catenin nor APC gene mutation was detected in all of the cases with nuclear expression of beta-catenin.
CONCLUSIONS: Our results indicate that the role beta-catenin plays in the genesis of gastrointestinal and extragastrointestinal carcinoid tumors is different. Nuclear expression of beta-catenin does not occur in extragastrointestinal carcinoid tumors, and mutation of exon 3 of beta-catenin gene and exon 15 of APC gene does not contribute to the activation of Wnt/beta-catenin/APC pathway in gastrointestinal carcinoid tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009161     DOI: 10.1245/s10434-006-9072-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.

Authors:  Kyle M Walsh; Murim Choi; Kjell Oberg; Matthew H Kulke; James C Yao; Chengqing Wu; Magdalena Jurkiewicz; Ling-I Hsu; Susanne M Hooshmand; Manal Hassan; Eva T Janson; Janet L Cunningham; Evan Vosburgh; Richard S Sackler; Richard P Lifton; Andrew T Dewan; Josephine Hoh
Journal:  Endocr Relat Cancer       Date:  2011-01-13       Impact factor: 5.678

2.  Repeated anastomotic recurrence of colorectal tumors: genetic analysis of two cases.

Authors:  Renato Costi; Cinzia Azzoni; Federico Marchesi; Lorena Bottarelli; Vincenzo Violi; Cesare Bordi
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

3.  Primary ovarian carcinoid tumor showing unusual histology and nuclear accumulation of β-catenin.

Authors:  Hyun-Soo Kim; Gun Yoon; Hye-In Jang; Sang Yong Song; Byoung-Gie Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

5.  Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.

Authors:  Ji Tae Kim; Jing Li; Eun Ryoung Jang; Pat Gulhati; Piotr G Rychahou; Dana L Napier; Chi Wang; Heidi L Weiss; Eun Y Lee; Lowell Anthony; Courtney M Townsend; Chunming Liu; B Mark Evers
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

Review 6.  Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.

Authors:  Scott N Pinchot; Susan C Pitt; Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Curr Opin Investig Drugs       Date:  2008-06

Review 7.  Molecular profiles of gastroenteropancreatic endocrine tumors.

Authors:  Aurel Perren; Martin Anlauf; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

Review 8.  Composite intestinal adenoma-microcarcinoid: An update and literature review.

Authors:  Zhi-Yan Fu; Michel Kmeid; Mahmoud Aldyab; Stephen M Lagana; Hwajeong Lee
Journal:  World J Gastrointest Endosc       Date:  2021-12-16

9.  Histopathology of gastrointestinal neuroendocrine neoplasms.

Authors:  Kenichi Hirabayashi; Giuseppe Zamboni; Takayuki Nishi; Akira Tanaka; Hiroshi Kajiwara; Naoya Nakamura
Journal:  Front Oncol       Date:  2013-01-22       Impact factor: 6.244

Review 10.  From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

Authors:  Giovanni Vitale; Alessandra Dicitore; Luigi Barrea; Emilia Sbardella; Paola Razzore; Severo Campione; Antongiulio Faggiano; Annamaria Colao; Manuela Albertelli; Barbara Altieri; Filomena Bottiglieri; Federica De Cicco; Sergio Di Molfetta; Giuseppe Fanciulli; Tiziana Feola; Diego Ferone; Francesco Ferraù; Marco Gallo; Elisa Giannetta; Federica Grillo; Erika Grossrubatscher; Elia Guadagno; Valentina Guarnotta; Andrea M Isidori; Andrea Lania; Andrea Lenzi; Fabio Lo Calzo; Pasquale Malandrino; Erika Messina; Roberta Modica; Giovanna Muscogiuri; Luca Pes; Genoveffa Pizza; Riccardo Pofi; Giulia Puliani; Carmen Rainone; Laura Rizza; Manila Rubino; Rosa Maria Ruggieri; Franz Sesti; Mary Anna Venneri; Maria Chiara Zatelli
Journal:  Rev Endocr Metab Disord       Date:  2020-09-15       Impact factor: 9.306

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.